InvestorsHub Logo

jamtomorrow2

08/16/16 12:10 PM

#4679 RE: Fred Kadiddlehopper #4678

I have absolutely no idea, which is presumably what PFE wants. But problems with the Keytruda, Docepaxal and now Bococizumab trials all within a few weeks is getting hard to stomach.